A detailed history of Gam Holding Ag transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gam Holding Ag holds 2,587 shares of REGN stock, worth $2.7 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
2,587
Previous 3,118 17.03%
Holding current value
$2.7 Million
Previous $3 Million 9.4%
% of portfolio
0.22%
Previous 0.23%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

SELL
$883.2 - $1071.19 $468,979 - $568,801
-531 Reduced 17.03%
2,587 $2.72 Million
Q4 2023

Jan 23, 2024

SELL
$775.18 - $881.7 $3,875 - $4,408
-5 Reduced 0.16%
3,118 $2.74 Million
Q3 2023

Oct 16, 2023

BUY
$692.45 - $844.37 $7,616 - $9,288
11 Added 0.35%
3,123 $2.57 Million
Q2 2023

Jul 27, 2023

SELL
$700.03 - $830.35 $2,800 - $3,321
-4 Reduced 0.13%
3,112 $2.24 Million
Q1 2023

May 09, 2023

BUY
$680.49 - $826.97 $112,961 - $137,277
166 Added 5.63%
3,116 $2.56 Million
Q4 2022

Feb 02, 2023

SELL
$705.89 - $766.39 $881,656 - $957,221
-1,249 Reduced 29.75%
2,950 $2.13 Million
Q3 2022

Oct 19, 2022

SELL
$573.97 - $724.32 $578,561 - $730,114
-1,008 Reduced 19.36%
4,199 $2.89 Million
Q2 2022

Jul 21, 2022

BUY
$548.35 - $738.84 $2.31 Million - $3.11 Million
4,208 Added 421.22%
5,207 $3.08 Million
Q1 2022

May 06, 2022

SELL
$595.12 - $698.43 $182,701 - $214,418
-307 Reduced 23.51%
999 $698,000
Q4 2021

Jan 26, 2022

SELL
$543.48 - $670.97 $233,152 - $287,846
-429 Reduced 24.73%
1,306 $825,000
Q3 2021

Nov 12, 2021

SELL
$574.03 - $680.96 $297,921 - $353,418
-519 Reduced 23.03%
1,735 $1.05 Million
Q2 2021

Aug 09, 2021

SELL
$472.8 - $558.54 $568,305 - $671,365
-1,202 Reduced 34.78%
2,254 $1.26 Million
Q1 2021

May 10, 2021

BUY
$446.73 - $548.2 $1.54 Million - $1.89 Million
3,456 New
3,456 $1.64 Million
Q4 2020

Feb 10, 2021

SELL
$478.3 - $607.98 $1.69 Million - $2.14 Million
-3,528 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$544.75 - $658.21 $11,439 - $13,822
21 Added 0.6%
3,528 $1.98 Million
Q2 2020

Aug 10, 2020

BUY
$493.32 - $643.92 $1.73 Million - $2.26 Million
3,507 New
3,507 $2.19 Million
Q4 2019

Feb 06, 2020

SELL
$274.13 - $376.51 $554,839 - $762,056
-2,024 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$273.46 - $318.39 $553,483 - $644,421
2,024 New
2,024 $561,000
Q2 2019

Aug 12, 2019

SELL
$299.6 - $414.82 $651,929 - $902,648
-2,176 Closed
0 $0
Q1 2019

May 10, 2019

BUY
$372.08 - $439.57 $337,104 - $398,250
906 Added 71.34%
2,176 $894,000
Q4 2018

Feb 08, 2019

SELL
$335.82 - $403.04 $106,454 - $127,763
-317 Reduced 19.97%
1,270 $474,000
Q3 2018

Nov 13, 2018

BUY
$351.14 - $408.51 $557,259 - $648,305
1,587 New
1,587 $641,000
Q3 2017

Nov 14, 2017

SELL
$431.38 - $504.0 $6.81 Million - $7.96 Million
-15,788 Closed
0 $0
Q2 2017

Aug 07, 2017

BUY
N/A
15,788
15,788 $7.75 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Gam Holding Ag Portfolio

Follow Gam Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.